Zota Health Care Limited has informed the Exchange regarding 'Postal Ballot Notice Response to Proxy Advisory Firm'.
ZOTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Zota Health Care has formally responded to proxy advisor IiAS regarding a postal ballot resolution that seeks shareholder approval to raise its Section 186 borrowing, investment, and guarantee limit from ₹500 crores to ₹1,000 crores. The company clarified that the headroom is not just for lending to its key subsidiary Davaindia Health Mart Limited but also covers strategic acquisitions, capitalising on investment opportunities, and supporting other subsidiaries. It noted that the existing ₹500 crore cap, approved by shareholders in March 2025, has already been exhausted through investments made using recently raised QIP funds. The company committed to full disclosure of loan/investment details in annual audited financial statements as required under Section 186(4) and assured that any related-party transactions, including with promoter-group entities, will comply with regulatory and governance norms. E-voting for the resolution is open from March 18, 2026 to April 16, 2026.
Indicates aggressive capital deployment plans, with the Davaindia retail expansion likely to remain the primary funding beneficiary. Retail investors should track the voting outcome and monitor related-party disclosures once the higher limit is approved.